Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... We have developed caffeine-potentiated chemotherapy for treatment of high-grade bone and soft tissue sarcomas based on the ability of caffeine to enhance the cytocidal ... of caffeine-potentiated chemotherapy for patients with osteosarcoma with pulmonary metastases. We analyzed retrospectively overall survival and some prognostic factors for 41 ...
2009 NOV 23 ... role of GDF-15 in modulation of osteoclast differentiation and possibly in therapy of bone metastases." Vanhara and colleagues published their study in Differentiation ...
2009 NOV 16 ... currently in Phase II development. This product aims to allow cancer patients with bone metastases to take a weekly tablet to get the gold standard treatment in this area, rather than an ...
2009 NOV 16 ... currently in Phase II development. This product aims to allow cancer patients with bone metastases take a weekly tablet to get the gold standard treatment in this area, rather than an IV ...
2009 NOV 9 ... is an urgent need to improve the prediction Of fracture risk for cancer patients with bone metastases. The methods that are Currently used to estimate fracture Fisk are dissatisfying, hence ...
2009 NOV 9 ... According to a study from the United States, "Bone metastases are the most common skeletal complication of malignancy." "Tumor cells ...
2009 NOV 16 ... 47 years (range 20-65) representing 21 diagnoses. Main exclusion criteria were brain or bone metastases. 235 patients completed follow-up. Supervised exercise comprising high intensity ...
2009 NOV 27 ... Chemistry, "The radiopharmaceutical [Sm-153]Sm-EDTMP is administered for painful bone metastases with the standard dosage of 37 MBq/kg, without evaluation of patient individual ...
2009 NOV 9 ... patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, ... cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), ...
2009 NOV 2 ... A report, 'Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases,' is newly published data in Cancer Science. According to recent research published in ...
2009 NOV 9 ... detected more metastatic sites (133 v 112, P = .03), detecting significantly more bone and subcutaneous metastases. Treatment changed in 19% of patients; in 79% as a result of ...
2009 NOV 2 ... Fresh data on osteosarcoma are presented in the report 'Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions.' According to a study from the ... for osteosarcoma metastasis, and Fas downregulation is necessary for survival of metastases in lungs. As little is known about chondrosarcoma signaling, more preclinical work is ...
2009 NOV 23 ... case in which bisphosphonate zoledronic acid (ZA) effectively treated not only multiple bone metastases but also lung, pleural and liver metastases from renal cell carcinoma (RCC). Recently, ...
2009 NOV 9 ... had significantly more liver metastases, a trend for more brain metastases, and less bone metastases. There was a strong trend for more visceral metastases in the FIR-negative group," ...
2009 NOV 23 ... with a positive bone scan. The PET findings were also negative in 6 of 9 osteogenic bone metastases and one of 64 osteolytic bone lesions. There were 5 cases with false-positive of PET, ...
2009 NOV 16 ... from Tsu, Japan, "Osteosarcoma (OS) is the most common primary malignant tumor of the bone and often forms pulmonary metastases, which are the most important prognostic factor. ...
2009 NOV 2 ... expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours,' is the subject of a report. "Fibroblast activation protein ... membrane proteases. They are involved in tissue remodelling, cancer invasion and metastases, mechanisms that are controversial," scientists writing in the journal Histopathology ...
2009 NOV 23 ... underwent surgical successful resection. But 6 months later, he developed extensive bone, liver, and lymph nodes metastasis, which were demonstrated by computed tomography scan ... He and colleagues published their study in Endocrine (Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma. Endocrine, ...
2009 NOV 23 ... Data detailed in 'Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning ... benign lesion. In nine patients (19 scan pairs), both studies were negative. All osseous metastases identified on bone scan were present on PET. Many additional sites of bony involvement ...
